NanoVector licenses biologic nanoparticle drug-delivery technology

12/4/2008 | Nanotechnology Now

NanoVector has licensed a plant-virus nanoparticle drug-delivery system designed for the selective targeting of tumors and the intracellular delivery of anti-cancer drugs. The system, which was developed by researchers at North Carolina State University, could help improve the efficacy of cytotoxic drugs and reduce their adverse side effects.

View Full Article in:

Nanotechnology Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Regulatory Affairs Specialist
Becton Dickinson
Franklin Lakes, NJ
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
President/Chief Executive Officer
Winston-Salem, NC